Announced Mon, 20 Jul · 22:46 IST
Shareholders approve reappointment and new Independent Director at Gland Pharma
Management Changes View source PDF
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.8%1-day move
₹2458.20
prior close
₹2476.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.8-0.9-1.0-1.0-0.8-2.9-2.9-1.1——————
Up moveDown movePending
AI summary
Shareholders of Gland Pharma approved via postal ballot the reappointment of Mr. Udo J. Vetter as Independent Director for a second 5-year term (July 21, 2026 to July 20, 2031) and the appointment of Mr. William Robert Keller as Independent Director for 5 years (June 15, 2026 to June 14, 2031). Both will receive commission on profits as remuneration.
Likely market impact
Routine independent director appointments via shareholder approval. No material impact on operations or financials expected.